Printer Friendly

BIOPLASTY ANNOUNCES APPROVAL OF MERGER WITH BIO-MANUFACTURING

 BIOPLASTY ANNOUNCES APPROVAL OF MERGER WITH BIO-MANUFACTURING
 ST. PAUL, Minn., May 28 /PRNewswire/ -- Bioplasty, Inc. (NASDAQ: BIOP) announced today that the merger with its breast implant supplier, Bio-Manufacturing, Inc. (BMI) has been approved by a special vote of the BMI shareholders and will be made effective on or about May 29, 1992. Under the terms of the definitive Agreement and Plan of Reorganization and Merger, each BMI shareholder will be issued one share of registered Bioplasty common stock in exchange for every 10 BMI shares owned as of the effective date of merger. One option to purchase Bioplasty stock will also be granted in exchange for every 10 BMI options owned.
 After appropriate regulatory authorization is obtained, Bioplasty, Inc., intends to resume marketing its MISTI GOLD(TM) Bio-Oncotic(TM) Gel-Filled Mammary Prostheses in the United States and overseas. The merger with BMI will provide the combined entity with cost savings as to management personnel, and operational efficiencies, including administration, regulatory and financial reporting, and greater control over the manufacturing process.
 Bioplasty, Inc. has more than 20 years of experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on NASDAQ under the symbol "BIOP."
 -0- 5/28/92
 /CONTACT: Timothy P. Lawin or Donald A. Major, 612-636-4112, both of Bioplasty/
 (BIOP) CO: Bioplasty, Inc.; Bio-Manufacturing, Inc. ST: Minnesota IN: MTC SU: TNM


AL -- MN013 -- 4783 05/28/92 13:26 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 28, 1992
Words:238
Previous Article:WALLACE COMPUTER SERVICES ANNOUNCES THIRD QUARTER RESULTS
Next Article:GENERAL SEMICONDUCTOR TO SELL ITS IRISH OPERATIONS, OTHER ASSETS
Topics:


Related Articles
BIOPLASTY, INC., ANNOUNCES RECEIPT OF PATENT INFRINGEMENT COMPLAINT
FDA CALLS FOR A UNITED STATES MORATORIUM ON SILICONE GEL-FILLED BREAST IMPLANTS
BIOPLASTY ANNOUNCES STOCK DIVIDEND
BIO-MANUFACTURING ANNOUNCES 1991 EARNINGS
BIOPLASTY SUBMITS INVESTIGATIONAL DEVICE EXEMPTION (IDE) FOR ITS MISTI GOLD BREAST IMPLANTS
BIOPLASTY WITHDRAWS SUBMISSIONS FILED WITH FOOD AND DRUG ADMINISTRATION
BIOPLASTY ANNOUNCES THIRD QUARTER RESULTS OF OPERATIONS
VITAL IMAGES AGREES IN PRINCIPLE TO MERGER INTO BIO-VASCULAR, INC.
VITAL IMAGES SHAREHOLDERS TO VOTE MAY 24 ON MERGER INTO BIO-VASCULAR, INC.
MICRO BIO-MEDICS WHOLLY OWNED SUBSIDIARY FINALIZES MERGER AGREEMENT TO ACQUIRE STONE MEDICAL SUPPLY CORPORATION, A PHYSICIAN SUPPLY COMPANY

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters